𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sequential trial of initial chemotherapy for advanced cancer of the head and neck: DDP versus DDP + 5-fluorouracil

✍ Scribed by Paul Coninx; Salvator Nasca; Daniela Lebrun; Xavier Panis; Patrick Lucas; Edouard Garbe; Michel Legros

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
534 KB
Volume
62
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Chemotherapy of advanced head and neck c
Chemotherapy of advanced head and neck cancer: Updated results of a randomized trial of the order of administration of sequential methotrexate and 5-fluorouracil
✍ MacKintosh, John F. ;Coates, Alan S. ;Tattersall, M. H. N. ;Swanson, Cheryl πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 327 KB

One hundred and twenty-seven patients with advanced or recurrent squamous cell carcinoma of the head and neck (HNC) were randomized to treatment with methotrexate (MTX) followed 1 hour later by 5-fluorouracil (5-FU) (sequence MF), or 5-fluorouracil followed after 1 hour by methotrexate (sequence FM)

Cisplatin-5-fluorouracil chemotherapy fo
Cisplatin-5-fluorouracil chemotherapy for advanced inoperable squamous carcinoma of the head and neck
✍ Johnson, Jonas T. ;Mayernik, David G. ;Myers, Eugene N. ;Nolan, Teresa A. ;Schra πŸ“‚ Article πŸ“… 1987 πŸ› Wiley (John Wiley & Sons) βš– 368 KB πŸ‘ 2 views

Patients with locally advanced, inoperable squamous cell carcinoma of the head and neck were offered three courses of cisplatin and 96-h 5-fluorouracil (5-FU) infusion. Subsequent therapy included surgery when feasible, irradiation therapy, and a maintenance program of methotrexate (MTX)-5-FU. Thirt

cis-Platinum and 5-fluorouracil as initi
cis-Platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck
✍ Weaver, Arthur ;Fleming, Susan ;Vandenberg, Henry ;Drelichman, Anibal ;Jacobs, J πŸ“‚ Article πŸ“… 1982 πŸ› Wiley (John Wiley & Sons) βš– 397 KB

## Abstract A total of 44 patients with previously untreated Stage IV squamous cell carcinomas of the head and neck were treated with a combination of cis‐platinum (100 mg/sq m) and 96‐hour infusion of 5‐fluorouracil (5‐FU) (1,000 mg/sq m/day) in two courses or with cis‐platinum (100 mg/sq m) and 1

Survival results from a phase III study
Survival results from a phase III study of simultaneous versus 1-hour sequential methotrexateβ€”5-fluorouracil chemotherapy in head and neck cancer
✍ Browman, George P. ;Levine, Mark N. ;Russell, Rosemary ;Young, J. E. M. ;Archiba πŸ“‚ Article πŸ“… 1986 πŸ› Wiley (John Wiley & Sons) βš– 442 KB πŸ‘ 2 views

There were 79 patients with squamous Cell head and neck cancer randomized to receive simultaneous or 1 hour sequential methotrexate-5 fluorouracil (MTX-5-FU) chemotherapy: 47 patients were previously untreated and 32 patients had recurrent disease. The treatment groups were comparable for important